Bertin Nahum, a French entrepreneur of Beninese descent, is a co-founder and CEO of Quantum Surgical, a medical robotics company based in Montpellier.

Founded in 2017, Quantum Surgical designs and develops robotic systems for interventional surgery. The company's research focuses on improving cancer treatments, particularly for liver cancer, which continues to have a high mortality rate.

Quantum Surgical's flagship product is Epione, a robotic platform for image-guided percutaneous procedures. It enables targeted ablation of liver tumors with a high degree of precision. This technology is designed to improve success rates and broaden access to this form of treatment.

Epione incorporates artificial intelligence tools to optimize needle placement and surgical planning. It is marketed to specialized hospitals and interventional surgery practitioners, paving the way for wider use of robot-assisted surgery.

Quantum Surgical has received several awards, including the Prix Galien in 2022, a prestigious honor in the field of biopharmaceutical research. In 2023, the company was selected for the French Tech 2030 program, which supports emerging innovation leaders in France.

Nahum’s first company was Medtech SA, which developed and commercialized medical and surgical assistance technologies. Established in 2002, it was acquired by Zimmer Biomet in 2016.

An engineer who graduated from the National Institute of Applied Sciences in Lyon in 1994, Nahum also holds a master's degree in robotics from Coventry University in the United Kingdom.

Melchior Koba